Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000315066-25-000705
Filing Date
2025-02-12
Accepted
2025-02-12 09:08:29
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 6697
2 exhibit99.txt EX-99 2909
  Complete submission text file 0000315066-25-000705.txt   11331
Mailing Address 245 SUMMER STREET BOSTON MA 02210
Business Address 245 SUMMER STREET BOSTON MA 02210 6175706339
FMR LLC (Filed by) CIK: 0000315066 (see all company filings)

EIN.: 043532603 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G
SIC: 0000

Mailing Address 2500 INNOVATION WAY GREENFIELD IN 46140
Business Address 2500 INNOVATION WAY GREENFIELD IN 46140 877-352-6261
Elanco Animal Health Inc (Subject) CIK: 0001739104 (see all company filings)

EIN.: 825497352 | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-90921 | Film No.: 25612274
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)